Care Twentyone Corporation (TYO:2373)
410.00
+4.00 (0.99%)
Jul 1, 2025, 3:30 PM JST
Care Twentyone Revenue
Care Twentyone had revenue of 11.81B JPY in the quarter ending April 30, 2025, with 6.58% growth. This brings the company's revenue in the last twelve months to 47.06B, up 8.95% year-over-year. In the fiscal year ending October 31, 2024, Care Twentyone had annual revenue of 45.40B with 10.46% growth.
Revenue (ttm)
47.06B
Revenue Growth
+8.95%
P/S Ratio
0.12
Revenue / Employee
7.65M
Employees
6,153
Market Cap
5.54B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Oct 31, 2024 | 45.40B | 4.30B | 10.46% |
Oct 31, 2023 | 41.10B | 2.70B | 7.03% |
Oct 31, 2022 | 38.40B | 2.04B | 5.60% |
Oct 31, 2021 | 36.36B | 2.38B | 6.99% |
Oct 31, 2020 | 33.98B | 3.02B | 9.75% |
Oct 31, 2019 | Pro | Pro | Pro |
Oct 31, 2018 | Pro | Pro | Pro |
Oct 31, 2017 | Pro | Pro | Pro |
Oct 31, 2016 | Pro | Pro | Pro |
Oct 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Chugai Pharmaceutical | 1,222.12B |
Takeda Pharmaceutical Company | 4,581.55B |
Daiichi Sankyo Company | 1,886.26B |
HOYA Corporation | 866.03B |
Terumo | 1,036.17B |
Otsuka Holdings | 2,393.18B |
Astellas Pharma | 1,912.32B |
Shionogi & | 438.27B |